IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Avalanche Biotechnologies, Inc. And Advises Shareholders To Contact The Firm Prior To The Lead Plaintiff Deadline

LOS ANGELES--()--Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California against (“Avalanche” or the “Company”) (NASDAQ: AAVL), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between July 31, 2014 and June 15, 2015, inclusive (the “Class Period”), have until September 8, 2015 to serve as lead plaintiff in the class action. In addition, investors who purchased shares traceable to the Company’s Initial Public Offering (“IPO”) on January July 31, 2014, should contact the firm to discuss this action.

If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Avalanche is a biotechnology company engaged in the development of gene therapies for patients with various ophthalmic diseases. According to the complaint, on June 15, 2015, Avalanche held a conference call to discuss their Phase IIa trial results concerning a gene therapy treatment for wet age-related macular degeneration. During the call Avalanche stated that the study was not designed to demonstrate statistically significant differences between the active and control groups. As a result, shares dropped over 56% the following day to end at $17.05 on June 16, 2015.

If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq. 800-977-7401
Brian Schall, Esq. 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com
https://twitter.com/goldberglawpc
https://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts

Contacts

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq. 800-977-7401
Brian Schall, Esq. 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com
https://twitter.com/goldberglawpc
https://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts